Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were ser...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2022, Vol.2 (1), p.e93-e93, Article e93
Main Authors: Bosserman, Rachel E, Farnsworth, Christopher W, O'Neil, Caroline A, Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A, Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J, Budge, Philip J, Olsen, Margaret A, Burnham, Carey-Ann D, Babcock, Hilary M, Kwon, Jennie H
Format: Article
Language:English
Subjects:
Concise Communication
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2022.231